Requirement for the histone deacetylase Hdac3 for the inflammatory gene expression program in macrophages

Proceedings of the National Academy of Sciences of the United States of America

Volumn 109, Issue 42, 2012, Pages

  Chen, Xuefen ^a   Barozzi, Iros ^b   Termanini, Alberto ^b   Prosperini, Elena ^b   Recchiuti, Antonio ^c   Dalli, Jesmond ^d   Mietton, Flore ^b   Matteoli, Gianluca ^b   Hiebert, Scott ^e   Natoli, Gioacchino ^b  

^a ISTITUTO ITALIANO DI TECNOLOGIA   (Italy)

^b EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^c Centro di Scienze dell'Invecchiamento   (Italy)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e VANDERBILT UNIVERSITY   (United States)

Author keywords

Chromatin; Transcription

Indexed keywords

BETA INTERFERON; CELL NUCLEUS RECEPTOR; CYCLOOXYGENASE 1; HISTONE DEACETYLASE 3; LIPOPOLYSACCHARIDE; STAT1 PROTEIN;

ANIMAL CELL; ARTICLE; AUTOCRINE EFFECT; CONTROLLED STUDY; GENE EXPRESSION; GENE MAPPING; GENE REPRESSION; HISTONE ACETYLATION; MACROPHAGE; MOUSE; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

ANIMALS; BASE SEQUENCE; CHROMATIN IMMUNOPRECIPITATION; CYCLOOXYGENASE 1; CYTOKINES; DNA PRIMERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENOMICS; HISTONE DEACETYLASES; MACROPHAGES; MEMBRANE PROTEINS; MICE; MICE, TRANSGENIC; MOLECULAR SEQUENCE DATA; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA;

EID: 84867652835     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1121131109     Document Type: Article

References (57)

1. Medzhitov R, Horng T (2009) Transcriptional control of the infl ammatory response. Nat Rev Immunol 9:692-703.
2. Smale ST (2010) Selective transcription in response to an inflammatory stimulus. Cell 140:833-844.
3. Natoli G, Ghisletti S, Barozzi I (2011) The genomic landscapes of inflammation. Genes Dev 25:101-106.
4. Amit I, et al. (2009) Unbiased reconstruction of a mammalian transcriptional network mediating pathogen responses. Science 326:257-263.
5. Perissi V, Aggarwal A, Glass CK, Rose DW, Rosenfeld MG (2004) A corepressor/coactivator exchange complex required for transcriptional activation by nuclear receptors and other regulated transcription factors. Cell 116:511-526. (Pubitemid 38264429)
6. Covic M, et al. (2005) Arginine methyltransferase CARM1 is a promoter-specific regulator of NF-kappaB-dependent gene expression. EMBO J 24:85-96. (Pubitemid 40188466)
7. De Santa F, et al. (2009) Jmjd3 contributes to the control of gene expression in LPS-activated macrophages. EMBO J 28:3341-3352.
8. van Essen D, Zhu Y, Saccani S (2010) A feed-forward circuit controlling inducible NF-κBtarget gene activation by promoter histone demethylation. Mol Cell 39:750-760.
9. Ramirez-Carrozzi VR, et al. (2009) A unifying model for the selective regulation of inducible transcription by CpG islands and nucleosome remodeling. Cell 138:114-128.
10. Hargreaves DC, Horng T, Medzhitov R (2009) Control of inducible gene expression by signal-dependent transcriptional elongation. Cell 138:129-145.
11. Nicodeme E, et al. (2010) Suppression of inflammation by a synthetic histone mimic. Nature 468:1119-1123.
12. Leoni F, et al. (2002) The antitumor histone deacetylase inhibitor suberoylanilide hydroxamic acid exhibits antiinflammatory properties via suppression of cytokines. Proc Natl Acad Sci USA 99:2995-3000. (Pubitemid 34240574)
13. Grabiec AM, et al. (2010) Histone deacetylase inhibitors suppress inflammatory activation of rheumatoid arthritis patient synovial macrophages and tissue. J Immunol 184:2718-2728.
14. Shakespear MR, Halili MA, Irvine KM, Fairlie DP, Sweet MJ (2011) Histone deacetylases as regulators of inflammation and immunity. Trends Immunol 32:335-343.
15. Minucci S, Pelicci PG (2006) Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer. Nat Rev Cancer 6:38-51. (Pubitemid 43054973)
16. Choudhary C, et al. (2009) Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science 325:834-840.
17. Dhalluin C, et al. (1999) Structure and ligand of a histone acetyltransferase bromodomain. Nature 399:491-496. (Pubitemid 29258857)
18. Wen YD, et al. (2000) The histone deacetylase-3 complex contains nuclear receptor corepressors. Proc Natl Acad Sci USA 97:7202-7207.
19. Hörlein AJ, et al. (1995) Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor. Nature 377:397-404.
20. Chen JD, Evans RM (1995) A transcriptional co-repressor that interacts with nuclear hormone receptors. Nature 377:454-457.
21. Perissi V, Jepsen K, Glass CK, Rosenfeld MG (2010) Deconstructing repression: Evolving models of co-repressor action. Nat Rev Genet 11:109-123.
22. Wang A, Kurdistani SK, Grunstein M (2002) Requirement of Hos2 histone deacetylase for gene activity in yeast. Science 298:1412-1414. (Pubitemid 35346139)
23. Pijnappel WW, et al. (2001) The S. cerevisiae SET3 complex includes two histone deacetylases, Hos2 and Hst1, and is a meiotic-specific repressor of the sporulation gene program. Genes Dev 15:2991-3004. (Pubitemid 33078949)
24. Yang XJ, Seto E (2008) The Rpd3/Hda1 family of lysine deacetylases: From bacteria and yeast to mice and men. Nat Rev Mol Cell Biol 9:206-218.
25. Kim T, Buratowski S (2009) Dimethylation of H3K4 by Set1 recruits the Set3 histone deacetylase complex to 5′ transcribed regions. Cell 137:259-272.
26. Gough DJ, et al. (2010) Functional crosstalk between type I and II interferon through the regulated expression of STAT1. PLoS Biol 8:e1000361.
27. Dubois RN, et al. (1998) Cyclooxygenase in biology and disease. FASEB J 12:1063-1073.
28. Bhaskara S, et al. (2008) Deletion of histone deacetylase 3 reveals critical roles in S phase progression and DNA damage control. Mol Cell 30:61-72. (Pubitemid 351470157)
29. Yamamoto M, et al. (2003) Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science 301:640-643. (Pubitemid 36927946)
30. Doyle S, et al. (2002) IRF3 mediates a TLR3/TLR4-specific antiviral gene program. Immunity 17:251-263. (Pubitemid 35279547)
31. Heintzman ND, et al. (2007) Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome. Nat Genet 39: 311-318. (Pubitemid 46328487)
32. Ghisletti S, et al. (2010) Identification and characterization of enhancers controlling the inflammatory gene expression program in macrophages. Immunity 32:317-328.
33. Heinz S, et al. (2010) Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol Cell 38:576-589.
34. Schonthaler HB, Guinea-Viniegra J, Wagner EF (2011) Targeting inflammation by modulating the Jun/AP-1 pathway. Ann Rheum Dis 70(Suppl 1):i109-i112.
35. Ogawa S, et al. (2004) A nuclear receptor corepressor transcriptional checkpoint controlling activator protein 1-dependent gene networks required for macrophage activation. Proc Natl Acad Sci USA 101:14461-14466. (Pubitemid 39346771)
36. Cheng CS, et al. (2011) The specificity of innate immune responses is enforced by repression of interferon response elements by NF-κB p50. Sci Signal 4:ra11.
37. Nguyen T, Nioi P, Pickett CB (2009) The Nrf2-antioxidant response element signaling pathway and its activation by oxidative stress. J Biol Chem 284: 13291-13295.
38. Hu Y, et al. (2010) Overcoming resistance to histone deacetylase inhibitors in human leukemia with the redox modulating compound β-phenylethyl isothiocyanate. Blood 116:2732-2741.
39. Sugimoto Y, Narumiya S (2007) Prostaglandin E receptors. J Biol Chem 282: 11613-11617. (Pubitemid 47100657)
40. Groeger AL, et al. (2010) Cyclooxygenase-2 generates anti-inflammatory mediators from omega-3 fatty acids. Nat Chem Biol 6:433-441.
41. Ricote M, Li AC, Willson TM, Kelly CJ, Glass CK (1998) The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature 391:79- 82.
42. Straus DS, et al. (2000) 15-deoxy-delta 12,14-prostaglandin J2 inhibits multiple steps in the NF-kappa B signaling pathway. Proc Natl Acad Sci USA 97:4844-4849. (Pubitemid 30238645)
43. Rossi A, et al. (2000) Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IkappaB kinase. Nature 403:103-108. (Pubitemid 30038530)
44. Xu XJ, Reichner JS, Mastrofrancesco B, Henry WL, Jr., Albina JE (2008) Prostaglandin E2 suppresses lipopolysaccharide-stimulated IFN-beta production. J Immunol 180: 2125-2131.
45. Sun H, Sheveleva E, Chen QM (2008) Corticosteroids induce cyclooxygenase 1 expression in cardiomyocytes: role of glucocorticoid receptor and Sp3 transcription factor. Mol Endocrinol 22:2076-2084.
46. Yang R, Chiang N, Oh SF, Serhan CN (2011) Metabolomics-lipidomics of eicosanoids and docosanoids generated by phagocytes. Curr Protoc Immunol, Chapter 14:Unit 14.26.
47. Kim BH, et al. (2011) A family of IFN-γ-inducible 65-kD GTPases protects againstbacterial infection. Science 332:717-721.
48. Wolter S, et al. (2008) c-Jun controls histone modifications, NF-kappaB recruitment, and RNA polymerase II function to activate the ccl2 gene. Mol Cell Biol 28:4407-4423. (Pubitemid 351904962)
49. Mullican SE, et al. (2011) Histone deacetylase 3 is an epigenomic brake in macrophage alternative activation. Genes Dev 25:2480-2488.
50. Lawrence T, Natoli G (2011) Transcriptional regulation of macrophage polarization: Enabling diversity with identity. Nat Rev Immunol 11:750-761.
51. Martinez FO, Helming L, Gordon S (2009) Alternative activation of macrophages: An immunologic functional perspective. Annu Rev Immunol 27:451-483.
52. Bieliauskas AV, Pflum MK (2008) Isoform-selective histone deacetylase inhibitors. Chem Soc Rev 37:1402-1413.
53. Bantscheff M, et al. (2011) Chemoproteomics profiling of HDAC inhibitors reveals selective targeting of HDAC complexes. Nat Biotechnol 29:255-265.
54. Park EJ, et al. (2010) Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression. Cell 140:197-208.
55. Barozzi I, Termanini A, Minucci S, Natoli G (2011) Fish the ChIPs: A pipeline for automated genomic annotation of ChIP-Seq data. Biol Direct 6:51.
56. Dickins RA, et al. (2005) Probing tumor phenotypes using stable and regulated synthetic microRNA precursors. Nat Genet 37:1289-1295. (Pubitemid 41568715)
57. De Santa F, et al. (2007) The histone H3 lysine-27 demethylase Jmjd3 links inflammation to inhibition of polycomb-mediated gene silencing. Cell 130: 1083-1094. (Pubitemid 47410272)